DR
Chief Scientific Officer, Modus Therapeutics
Dr. Reina Mostafavi '02
Reshaping how the FDA evaluates AI-designed molecules.
Read profile →
The Cornell Post tracks alumni leading in business, science, government, and the arts — across 175 countries and every industry.
Reshaping how the FDA evaluates AI-designed molecules.
Quietly built Manhattan's most influential biotech investment desk.
Architect of the administration's semiconductor and AI strategy.
Took grid-scale battery software from a Cornell Tech demo day to a $4B IPO.
First American principal in the orchestra's history.
Three decades of work at the intersection of diplomacy and finance.
Alumni in C-suite, board, and senior partner roles across the Fortune 500.
Startup founders, general partners, and the capital flowing between them.
Diplomats, judges, ministers, and humanitarian leaders worldwide.